226 related articles for article (PubMed ID: 15717642)
1. Effect of fenoldopam mesylate in critically ill patients at risk for acute renal failure is dose dependent.
Samuels J; Finkel K; Gubert M; Johnson T; Shaw A
Ren Fail; 2005; 27(1):101-5. PubMed ID: 15717642
[TBL] [Abstract][Full Text] [Related]
2. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients.
Brienza N; Malcangi V; Dalfino L; Trerotoli P; Guagliardi C; Bortone D; Faconda G; Ribezzi M; Ancona G; Bruno F; Fiore T
Crit Care Med; 2006 Mar; 34(3):707-14. PubMed ID: 16505657
[TBL] [Abstract][Full Text] [Related]
3. Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients.
Ranucci M; Soro G; Barzaghi N; Locatelli A; Giordano G; Vavassori A; Manzato A; Melchiorri C; Bove T; Juliano G; Uslenghi MF
Ann Thorac Surg; 2004 Oct; 78(4):1332-7; discussion 1337-8. PubMed ID: 15464494
[TBL] [Abstract][Full Text] [Related]
4. Renal effects of fenoldopam in critically ill pediatric patients: A retrospective review.
Moffett BS; Mott AR; Nelson DP; Goldstein SL; Jefferies JL
Pediatr Crit Care Med; 2008 Jul; 9(4):403-6. PubMed ID: 18496409
[TBL] [Abstract][Full Text] [Related]
5. The outcome of acute renal failure in the intensive care unit according to RIFLE: model application, sensitivity, and predictability.
Abosaif NY; Tolba YA; Heap M; Russell J; El Nahas AM
Am J Kidney Dis; 2005 Dec; 46(6):1038-48. PubMed ID: 16310569
[TBL] [Abstract][Full Text] [Related]
6. Fenoldopam in critically ill patients with early renal dysfunction. A crossover study.
Cobas M; Paparcuri G; De La Pena M; Cudemus G; Barquist E; Varon A
Cardiovasc Ther; 2011 Aug; 29(4):280-4. PubMed ID: 20955210
[TBL] [Abstract][Full Text] [Related]
7. Acute renal failure in critically ill surgical patients: persistent lethality despite new modes of renal replacement therapy.
Eachempati SR; Wang JC; Hydo LJ; Shou J; Barie PS
J Trauma; 2007 Nov; 63(5):987-93. PubMed ID: 17993940
[TBL] [Abstract][Full Text] [Related]
8. Effect of acute kidney injury on weaning from mechanical ventilation in critically ill patients.
Vieira JM; Castro I; Curvello-Neto A; Demarzo S; Caruso P; Pastore L; Imanishe MH; Abdulkader RC; Deheinzelin D
Crit Care Med; 2007 Jan; 35(1):184-91. PubMed ID: 17080002
[TBL] [Abstract][Full Text] [Related]
9. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial.
Bove T; Landoni G; Calabrò MG; Aletti G; Marino G; Cerchierini E; Crescenzi G; Zangrillo A
Circulation; 2005 Jun; 111(24):3230-5. PubMed ID: 15967861
[TBL] [Abstract][Full Text] [Related]
10. Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy.
Stone GW; Tumlin JA; Madyoon H; Lepor NE; McCullough PA; Mathur VS; Murray PT; O'Neill WW
Rev Cardiovasc Med; 2001; 2 Suppl 1():S31-6. PubMed ID: 12439366
[TBL] [Abstract][Full Text] [Related]
11. Intermittent hemodialysis versus continuous renal replacement therapy for acute renal failure in the intensive care unit: an observational outcomes analysis.
Rauf AA; Long KH; Gajic O; Anderson SS; Swaminathan L; Albright RC
J Intensive Care Med; 2008; 23(3):195-203. PubMed ID: 18474503
[TBL] [Abstract][Full Text] [Related]
12. N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery.
Barr LF; Kolodner K
Crit Care Med; 2008 May; 36(5):1427-35. PubMed ID: 18434903
[TBL] [Abstract][Full Text] [Related]
13. A case series of low-dose fenoldopam in seventy cardiac surgical patients at increased risk of renal dysfunction.
Garwood S; Swamidoss CP; Davis EA; Samson L; Hines RL
J Cardiothorac Vasc Anesth; 2003 Feb; 17(1):17-21. PubMed ID: 12635055
[TBL] [Abstract][Full Text] [Related]
14. Fenoldopam reduces the incidence of renal replacement therapy after cardiac surgery.
Roasio A; Lobreglio R; Santin A; Landoni G; Verdecchia C
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):23-6. PubMed ID: 18249326
[TBL] [Abstract][Full Text] [Related]
15. Dopamine "renal dose" versus fenoldopam mesylate to prevent ischemia-reperfusion injury in renal transplantation.
Fontana I; Germi MR; Beatini M; Fontana S; Bertocchi M; Porcile E; Saltalamacchia L; Ornis S; Ghinolfi D; Bonifazio L; Valente U
Transplant Proc; 2005; 37(6):2474-5. PubMed ID: 16182714
[TBL] [Abstract][Full Text] [Related]
16. Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies.
Benoit DD; Hoste EA; Depuydt PO; Offner FC; Lameire NH; Vandewoude KH; Dhondt AW; Noens LA; Decruyenaere JM
Nephrol Dial Transplant; 2005 Mar; 20(3):552-8. PubMed ID: 15671075
[TBL] [Abstract][Full Text] [Related]
17. Relationship between fluid status and its management on acute renal failure (ARF) in intensive care unit (ICU) patients with sepsis: a prospective analysis.
Van Biesen W; Yegenaga I; Vanholder R; Verbeke F; Hoste E; Colardyn F; Lameire N
J Nephrol; 2005; 18(1):54-60. PubMed ID: 15772923
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of infection in critically ill patients with acute renal failure.
Reynvoet E; Vandijck DM; Blot SI; Dhondt AW; De Waele JJ; Claus S; Buyle FM; Vanholder RC; Hoste EA
Crit Care Med; 2009 Jul; 37(7):2203-9. PubMed ID: 19487937
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of critically ill patients with cancer and acute renal dysfunction.
Soares M; Salluh JI; Carvalho MS; Darmon M; Rocco JR; Spector N
J Clin Oncol; 2006 Aug; 24(24):4003-10. PubMed ID: 16921054
[TBL] [Abstract][Full Text] [Related]
20. SAPS 3 at dialysis commencement is predictive of hospital mortality in patients supported by extracorporeal membrane oxygenation and acute dialysis.
Tsai CW; Lin YF; Wu VC; Chu TS; Chen YM; Hu FC; Wu KD; Ko WJ;
Eur J Cardiothorac Surg; 2008 Dec; 34(6):1158-64. PubMed ID: 18757205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
